Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
Surgical excision is the first-choice treatment for basal cell carcinoma (BCC). Other treatments with topical agents such as 5-fluoruracil or imiquimod have also been suggested for use in superficial BCC (sBCC). Ingenol mebutate (IM) is a novel agent employed in the treatment of superficial actinic...
Guardado en:
Autores principales: | Silvia S. Iannazzone, Vito Ingordo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd0850f3fbb94610801cd8d07e34fc84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravascular Basal Cell Carcinoma Hiding under a Keratoacanthoma
por: Austin Dunn, et al.
Publicado: (2021) -
Basal cell carcinoma: variation in invasion depth by subtype, sex, and anatomic site in 4,565 cases
por: John H. Pyne, et al.
Publicado: (2018) -
Aggressive basal cell carcinoma: dermatoscopy vascular features as clues to the diagnosis
por: John Pyne, et al.
Publicado: (2012) -
Large Pore Basal Cell Carcinoma: A Case Report
por: Ana Ines Lösch, et al.
Publicado: (2021) -
Influence of the glutathione s-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma
por: Leite,Janaína L, et al.
Publicado: (2007)